Eli Lilly said on Friday the U.S. Food and Drug Administration approved its eczema drug for use in adults and children above ...
This health news brief covers significant updates including the FDA's approval of new therapies for multiple sclerosis and ...
Independent advisers to the U.S. Food and Drug Administration voted on Friday against confirmatory trial data for Intercept Pharmaceuticals' liver disease drug, putting into question the treatment's ...
The U.S. Food and Drug Administration has allowed the expanded use of Johnson & Johnson's drug, Tremfya, to treat adults with ...
Staff reviewers at the U.S. Food and Drug Administration said on Wednesday a confirmatory trial did not show the ...
A Gallup poll has found that consumers' confidence in food safety has dropped by 23 points between 2006 to 2024 ...
Harris touts the IRA's drug pricing measures which reduce Medicare beneficiary out-of-pocket costs. If elected her quest to ...
Novo Nordisk's liraglutide has been approved for children who are at least 12 years old. However, the drug is now being ...
The Breakthrough Therapy designation stems from the provisions of 《Food and Drug Administration Safety and Innovation Act》.
From reporting metrics to how the FDA investigation process works, several major questions are looming for industries impacted by the rule, a new report found.
The legislation would allow the FDA to warn and fine companies and individuals who post false information online about medications such as Ozempic and Wegovy.
Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix products, today announced a landmark achievement ...